Johnson & Johnson's robotic surgery device gets US FDA marketing authorization
JNJ•FDA authorization clears path for Ottava launch
Johnson & Johnson said on Wednesday the U.S. Food and Drug Administration had granted marketing authorization for its Ottava robotic surgical system, clearing the way for the healthcare conglomerate to enter the U.S. soft-tissue robotic surgery market.
